Dementia with leukoaraiosis: Clinical differentiation by temporoparietal hypometabolism on 18FDG-PET imaging

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 6, 1999, Pages 518-525

  Mendez, Mario F ^a,b   Ottowitz, William ^a   Brown, Charles V ^a   Cummings, Jeffrey L ^b   Perryman, Kent M ^a,b   Mandelkern, Mark A ^a,c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Leukoaraiosis; Positron emission tomography; Vascular dementia

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; HUMAN; LEUKOARAIOSIS; MEMORY; MULTIINFARCT DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHITE MATTER;

AGED; CEREBROVASCULAR DISORDERS; DEMENTIA; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; RISK FACTORS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032732399     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017199     Document Type: Article

References (60)

1. Desmond DW: Vascular dementia: A construct in evolution. Cerebrovasc Brain Metab Rev 1996;8:296-325.
2. Hebert R, Brayne C: Epidemiology of vascular dementia. Neuroepidemiology 1995;14:240-257.
3. Shen YC, Li G, Li YT, Chen CH, Li SR, Zhao YW, Zhang WX: Epidemiology of age-related dementia in China. Chin Med J 1994;107:60-64.
4. Skoog I, Nilsson L, Palmertz B, Adreasson LA, Svanborg A: A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328:153-158.
5. Erkinjuntti T: Vascular dementia: Challenge of clinical diagnosis. Int Psychogeriatr 1997;9: 51-58.
6. Garcia JH, Brown GG: Vascular dementia: Neuropathologic alterations and metabolic brain changes. J Neurol Sci 1992;109:121-131.
7. Van Gijn J: Leukoaraiosis and vascular dementia. Neurology 1998;51(suppl 3):S3-S8.
8. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A: Accuracy of the clinical diagnosis of vascular dementia: A prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
9. Kidwell CS, Saver JL: Causes and consequences of leukoaraiosis: A review. Facts Res Gerontol 1996(suppl stroke):115-135.
10. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill-Gutierrez G, Goldberg MA, Berman NG: Neuropsychological correlates of white-matter lesions in healthy elderly subjects: A threshold effect. Arch Neurol 1992;49:549-554.
11. Liu CK, Miller BL, Cummings JL, Behringer CM, Goldberg MA, Howng SL, Benson DF: A quantitative MRI study of vascular dementia. Neurology 1992;42:138-143.
12. Bowen GC, Barker WW, Loewenstein DA, Sheldon J, Duara R: MR signal abnormalities in memory disorder and dementia. AJR 1990; 154:1285-1292.
13. Hendrie HC, Farlow MR, Austrom MG, Edwards MK, Williams MA: Foci of increased T2 signal intensity on brain MR scans of healthy elderly subjects. AJNR 1989;10:703-707.
14. Steingart A, Hachinski V, Lau C, Fox AJ, Diaz F, Cape R, Lee D, Inzitari D, Merskey H: Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987;44:36-39.
15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: diagnostic criteria for research studies. Neurology 1993;43:250-260.
16. Kennedy AM: Functional neuroimaging in dementia; in Growdon JH, Rossor MN (eds): The Dementias. London, Butterworth-Heinemann, 1998, pp 219-256.
17. DeCarli D, Grady DL, Clark DM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, et al: Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry 1996;60:158-167.
18. Salmon E, Sadzot B, Maquet P, Degueldre C, Lemaire C, Rigo P, Comar D, Franck G: Differential diagnosis of Alzheimer's disease with PET. J Nucl Med 1994;35:391-398.
19. Shyu WC, Lin JC, Shen CC, Hsu YD, Lee CC, Shiah IS, Tsao WL: Vascular dementia of Binswanger's type: Clinical, neuroradiological and 99mTc-HMPAO SPET study. Eur J Nucl Med 1996;23:1338-1344.
20. De Reuck J, Decoo D, Marchau M, Santens P, Lemahieu I, Strijckmans K: Positron emission tomography in vascular dementia. J Neurol Sci 1998;154:55-61.
21. De Reuck J, Decoo D, Strijckmans K, Lemahieu I: Does the severity of leukoaraiosis contribute to senile dementia? A comparative computerized and positron emission tomography study. Eur Neurol 1992;32:199-205.
22. Cummings JL, Benson DF: Dementia: A clinical Approach, ed 2. Boston, Butterworth, 1992.
23. Folstein MF, Folstein SE, McHugh PR: MiniMental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
26. Hachinski VC, Lassen NA, Marshall J: Multiinfarct dementia: A cause of mental deterioration in the elderly. Lancet 1974;ii:207-210.
27. Mantyla R, Erkinjuntti T, Salonen O, Aronen HJ, Pettonen T, Pohjasvaara T, Standertskjold-Nordenstam CG: Variable agreement between visual rating scales for white matter hyperintensities on MRI: Comparison of 13 rating scales in a poststroke cohort. Stroke 1997;28:1614-1623.
28. Meguro K, Hatazawa J, Yamaguchi T, Itoh M, Matsuzawa T, Ono S, Miyazawa H, Hishinuma T, Yanai K, Sekita Y: Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990;28:378-383.
29. Tohgi H, Yonezawa H, Takahashi S, Sato N, Kato E, Kudo M, Hatano K, Sasaki T: Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes. Neuroradiology 1998;40:131-137.
30. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H: Vascular risk factors and leukoaraiosis. Arch Neurol 1987;44:42-47.
31. Kidwell CS, Saver JL: Causes and consequences of white matter hyperintensities: A meta-analysis. Facts Res Gerontol 1996 (suppl stroke): 137-150.
32. Aharon-Peretz J, Cummings JL, Hill MA: Vascular dementia and dementia of the Alzheimer type: Cognition, ventricular size, and leukoaraiosis. Arch Neurol 1988;45:719-721.
33. Pantoni L, Garcia JH, Brown GG: Vascular pathology in three cases of progressive cognitive deterioration. J Neurol Sci 1996;135:131-139.
34. Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR: Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Arch Neurol 1985;42:951-959.
35. Scheinberg P: Dementia due to vascular disease: A multifactorial disorder. Stroke 1988;19: 1291-1299.
36. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC: Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol 1994;51:260-268.
37. Hulette C, Nochlin D, McKeel D, Morris JC, Mirra SS, Sumi SM, Heyman A: Clinical-neuropathologic findings in multi-infarct dementia: A report of six autopsied cases. Neurology 1997;48:668-672.
38. Del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J: Vascular dementia: A clinicopathological study. J Neurosci 1990;96:1-17.
39. Rao R, Howard R: Vascular dementia: Dead or alive? Int J Geriatr Psychiatry 1998;13:277-284.
40. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer's disease. JAMA 1997;277:813-817.
41. Waldemar G, Hogh P, Paulson OB: Functional brain imaging with single-photon emission computed tomography in the diagnosis of Alzheimer's disease. Int Psychogeriatr 1997;9: 223-227.
42. Mazziotta JC, Frackowiak RS, Phelps ME: The use of positron emission tomography in the clinical assessment of dementia. Semin Nucl Med 1992;22:233-246.
43. Herholz K: FDG PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 1995;9:6-16.
44. Nordberg A: Clinical studies in Alzheimer patients with positron emission tomography. Behav Brain Res 1993;57:215-224.
45. Masterman DL, Mendez MF, Fairbanks LA, Cummings JL: Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J Geriatr Psychiatry Neurol 1997;10:15-21.
46. Mayberg HS: Clinical correlates of PET- and SPECT-identified defects in dementia. J Clin Psychiatry 1994;55(suppl):12-21.
47. Hoffman JM, Hanson MW, Welsh KA, Earl N, Paine S, DeLong D, Coleman RE: Interpretation variability of 18FDG-positron emission tomography studies in dementia. Invest Radiol 1996;31:316-322.
48. Ibáñez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B: Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998;50:1585-1593.
49. Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD: HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: Comparison of perfusion and metabolic patterns. Eur J Nucl Med 1994;21:1052-1060.
50. Schapiro MB, Pietrini P, Grady C, Ball MJ, DeCarli C, Kumar A, Kaye JA, Haxby JV: Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. J Neurol Neurosurg Psychiatry 1993;56:859-864.
51. Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, Siegel BA, Morris JC, Berg L: Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. Neurology 1992;42:765-770.
52. Junque C, Pujol J, Vendrell P, Bruna O, Jodar M, Ribas JC, Vinas J, Capdevila A, Marti-Vilalta JL: Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 1990;47:151-156.
53. Filley CM: The behavioral neurology of cerebral white matter. Neurology 1998;50:1535-1540.
54. Mendez MF, Cherrier MM, Perryman KM: Differences between Alzheimer's disease and vascular dementia on information processing measures. Brain Cogn 1997;34:301-310.
55. Kertesz A, Polk M, Carr T: Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990;47: 387-391.
56. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology 1992; 42:473-480.
57. Lopez OL, Becker JT, Rezek D, Wess J, Boller F, Reynolds CF 3d, Panisset M: Neuropsychological correlates of cerebral white-matter radiolucencies in probable Alzheimer's disease. Arch Neurol 1992;49:828-834.
58. Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF: Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 1996;10:180-188.
59. Di Chirio G, Brooks RA: PET quantitation: Blessing and curse. J Nucl Med 1988;29:1603-1604.
60. Herholz K, Perani D, Salmon E, Franck G, Fazio F, Heiss WD, Comar D: Comparability of FDG-PET studies in probable Alzheimer's disease. J Nucl Med 1993;34:1460-1466.